PART I Overview We are a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients. We are leveraging our proprietary technology platforms to develop product candidates designed to target urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. We believe that our array of technology platforms uniquely positions us among other biotechnology c...
Q2 FY2026 — expected 2026-09-14
| Type | Subject | Detail | Quarter |
|---|---|---|---|
| topic_mention | PGEN | discussed_in_filing Cybersecurity | |
| topic_mention | PGEN | discussed_in_filing Trusted Computing | |
| topic_mention | PGEN | discussed_in_filing Blockchain & Crypto | |
| topic_mention | PGEN | discussed_in_filing Supply Chain | |
| topic_mention | PGEN | discussed_in_filing Regulation | |
| topic_mention | PGEN | discussed_in_filing Healthcare & Bio | |
| topic_mention | PGEN | discussed_in_filing Platform & Ecosystem | |
| topic_mention | PGEN | discussed_in_filing Sovereign & Government | |
| topic_mention | PGEN | discussed_in_filing Cybersecurity | |
| topic_mention | PGEN | discussed_in_filing Trusted Computing | |
| topic_mention | PGEN | discussed_in_filing Blockchain & Crypto | |
| topic_mention | PGEN | discussed_in_filing Supply Chain | |
| topic_mention | PGEN | discussed_in_filing Regulation | |
| topic_mention | PGEN | discussed_in_filing Healthcare & Bio | |
| topic_mention | PGEN | discussed_in_filing Platform & Ecosystem | |
| topic_mention | PGEN | discussed_in_filing Sovereign & Government | |
| topic_mention | PGEN | discussed_in_filing Cybersecurity | |
| topic_mention | PGEN | discussed_in_filing Trusted Computing | |
| topic_mention | PGEN | discussed_in_filing Blockchain & Crypto | |
| topic_mention | PGEN | discussed_in_filing Supply Chain |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-25 | 2025-12-31 | 0001356090-26-000009 | EDGAR | 81K words |
| 2025-03-19 | 2024-12-31 | 0001356090-25-000007 | EDGAR | — |
| 2024-03-19 | 2023-12-31 | 0001356090-24-000007 | EDGAR | — |
| 2023-03-06 | 2022-12-31 | 0001356090-23-000004 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0001356090-22-000002 | EDGAR | — |
| 2021-03-01 | 2020-12-31 | 0001356090-21-000003 | EDGAR | — |
| 2020-03-02 | 2019-12-31 | 0001628280-20-002699 | EDGAR | — |
| 2019-03-01 | 2018-12-31 | 0001356090-19-000004 | EDGAR | — |
| 2018-03-01 | 2017-12-31 | 0001356090-18-000002 | EDGAR | — |
| 2017-03-01 | 2016-12-31 | 0001356090-17-000003 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001356090-25-000034 | EDGAR | 27K words |
| 2025-08-12 | 2025-06-30 | 0001356090-25-000024 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001356090-25-000019 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001356090-24-000026 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0001356090-24-000017 | EDGAR | — |
| 2024-05-14 | 2024-03-31 | 0001356090-24-000010 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001356090-23-000017 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001356090-23-000013 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0001356090-23-000009 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001356090-22-000013 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0001356090-22-000009 | EDGAR | — |
| 2022-05-09 | 2022-03-31 | 0001356090-22-000006 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-25 | 0000950103-26-004648 | EDGAR | 3K words |
| 2025-11-13 | 0000950103-25-014683 | EDGAR | — |
| 2025-09-17 | 0000950103-25-011775 | EDGAR | — |
| 2025-09-03 | 0001104659-25-086669 | EDGAR | — |
| 2025-08-18 | 0000950103-25-010408 | EDGAR | — |
| 2025-08-18 | 0001104659-25-079497 | EDGAR | — |
| 2025-06-30 | 0000950103-25-008124 | EDGAR | — |
| 2025-05-14 | 0000950103-25-006004 | EDGAR | — |
| 2025-03-19 | 0000950103-25-003637 | EDGAR | — |
| 2025-01-16 | 0000950103-25-000576 | EDGAR | — |
227 total filings indexed. 195 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001356090 |
| Ticker | PGEN |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | VA |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report